Riskpilot← Back to searchSign inGet full accessPrima Vård 3 AB
ABActiveOrg 5567697064General medical practice activities · NACE 8621Est. 20080 employees
Revenue 2025
SEK 0
EBITDA margin
—
+63% vs 2024
Equity ratio
97.8%
Financial strength
Net profit 2025
SEK -467K
-140% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -33K | +63% |
| Net profit | SEK -467K | -140% |
| Total assets | SEK 56,8M | +0% |
| Equity | SEK 55,5M | -1% |
| Employees | 0 | — |
Legal name
Prima Vård 3 AB
Org number
5567697064
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 november 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva sjuk- och hälsovård samt därmed förenlig verksamhet. Management och Konsult verksamhet.
Address
Phone
+46705288550
Email
samuelsultani@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 066 | 135 | 827 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 941 | 67 | 611 | −91 | −33 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 1 941 | 67 | 611 | −91 | −33 |
| Net financials | — | 2 160 | 47 801 | 1 721 | 178 |
| Profit before tax | 1 941 | 2 227 | 48 213 | 1 629 | 344 |
| Tax | −415 | −14 | −127 | −457 | −812 |
| Net profit | 1 526 | 2 213 | 48 086 | 1 172 | −467 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 069 | 7 752 | 55 676 | 56 934 | 56 773 |
| Equity | 5 348 | 7 378 | 55 276 | 56 176 | 55 504 |
| Long-term debt | 0 | 302 | 0 | 0 | — |
| Short-term debt | 1 721 | 72 | 200 | 558 | 1 268 |
| Total debt | 1 721 | 374 | 200 | 558 | 1 268 |
EBITDA margin
-3343800.0%
This company
15.8%
Market median
-21163391% vs market
20212025
Equity ratio
97.8%
This company
38.2%
Market median
+156% vs market
20212025
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
20212025
Net profit margin
-46713600.0%
This company
8.1%
Market median
-576711211% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SS Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
FS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Prima Vård 3 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fahimeh Sultani | Deputy Chief Executive Officer | 0 companies |
| Samuel Sultani | Chief Executive Officer | 0 companies |
| Tulin Denise Deniz | Deputy Board Member | 0 companies |